2021 Research Forum and Keynote Lecture

2021 Research Forum and Keynote Lecture

43rd Annual Research Forum Allen Silbergleit , MD, PhD Keynote featuring Arnold S. Monto, MD May 26, 2021 8:00 am-12:30 pm Virtual Via Zoom This signature SEMCME Research Forum will recognize the remarkable research efforts made by over 35 residents from the SEMCME member institutions. All of the residents will be selected from clinic day competition at their respective institutions. Papers will represent the best of the best! . Approximately 10 research presentations live streamed on May 26 . Over 30 research presentations pre-recorded in voice-over PPT format accessible for viewing . Residents compete for cash prizes and awards including the David R. Pieper Research Award and the Donald Dawson Award . Annual Allen Silbergleit Lecture featuring Dr. Arnold Monto . Winners of live stream slide and recorded voice-over competitions will be announced immediately following keynote lecture Allen Silbergleit, MD, PhD Lecture 43RD ANNUAL RESEARCH FORUM KEYNOTE LECTURE May 26, 2021 11:15 am-12:15 pm Virtual Via Zoom The Impact of COVID-19: Where We Stand Arnold S. Monto, MD The Thomas Francis, Jr. Collegiate Professor Department of Epidemiology School of Public Health University of Michigan Ann Arbor, Michigan About the Allen Silbergliet, MD, PhD Lecture The Southeast Michigan Center for Medical Education established the Allen Silbergliet, MD, PhD Lecture (formerly the Meadow Brook Lecture Series in Medicine and Surgery) in 1977. The Lecture is designed to provide physicians in southeastern Michigan with a unique opportunity to hear internationally prominent persons in the forefront of medicine. The Lecture is held annually in conjunction with the SEMCME Research Forum. About the Speaker Arnold S. Monto is the Thomas Francis, Jr., Collegiate Professor of Public Health and Professor of Epidemiology at The University of Michigan School of Public Health in Ann Arbor. Dr. Monto chaired the US Food and Drug Administration's Vaccines and Related Biological Products Advisory Committee (VRBPAC) meetings in December that led to Emergency Use Authorization (EUA) of the Pfizer/BioNTech and Moderna vaccines. The major focus of Dr. Monto’s work has been the epidemiology, prevention, and treatment of acute infections in the individual and the community. Respiratory infections, particularly influenza, have been a major interest to Dr. Monto, with special reference to the evaluation of vaccines in various populations and the assessment of the value of antivirals. He has worked on these issues in tropical and temperate regions. He led the studies of respiratory infection in Tecumseh, Michigan, a landmark study of infection in the community. He has studied various approaches to influenza vaccine use, particularly to control transmission of the virus in the community. Dr. Monto is involved in assessing the efficacy of various types of influenza vaccine in prophylaxis and antivirals in prophylaxis and therapy of influenza, including implications of resistance. He now heads an observational study of effectiveness of influenza vaccines in various settings, including households. His recent activities have included evaluation of face masks and hand hygiene in the control of influenza transmission and determination of efficacy of the traditional inactivated and live attenuated influenza vaccines. Dr. Monto has been a member of the National Allergy and Infectious Diseases Advisory Council of the U.S. National Institutes of Health and is currently a member of the Vaccine and Related Biological Products Advisory Committee of the U.S. Department of Agriculture. He was past president of the American Epidemiological Society, the 2009 recipient of the Alexander Fleming Award of the Infectious Diseases Society of America for lifetime achievement, and the 2012 recipient of the Charles Merieux Award of the National Foundation for Infectious Diseases. He was a member of the emergency committee making recommendations to the World Health Organization during the most recent influenza pandemic. Audience The 2021Allen Silbergleit Lecture is intended for all physicians, residents, basic scientists, and faculty researchers. Registration There is no fee to attend the Research Forum and Allen Silbergleit Lecture. Registration is limited and will be on a first come, first served basis. A zoom link will be sent to registrants prior to the event. More information on the Research Forum and Lecture can be found at www.semcme.org or call SEMCME at 313-577-1237. To register for the Lecture (and/or Research Forum), click: REGISTER.

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    3 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us